Skip to Content

Penicillin G Benzathine

Last Updated: December 18, 2017
Status: Current

Penicillin G Benzathine

Products Affected - Description
  • All presentations are currently available

Reason for the Shortage
  • Pfizer states the shortage was due to a delay in the manufacturing process.

Available Products
  • Bicillin L-A intramuscular suspension for injection, Pfizer
    600,000 units, 1 mL syringe, 10 count (NDC 60793-0700-10)
    1,200,000 units, 2 mL syringe, 10 count (NDC 60793-0701-10)
    2,400,000 units, 4 mL syringe, 10 count (NDC 60793-0702-10)

Estimated Resupply Dates

  • Pfizer has Bicillin L-A 600,000 unit/ 1 mL syringes, 1,200,000 unit/ 2 mL syringes, and 2,400,000 unit/ 4 mL syringes available.

Implications for Patient Care

  • Bicillin L-A is the first line treatment of patients with syphilis. CDC is recommending conserving Bicillin L-A for patients with syphilis especially pregnant patients where the treatment choices are more limited. More information regarding treatment of syphilis including alternatives to Bicillin L-A.

Updated

December 18, November 10, October 30, August 29, June 25 and 5, April 3, February 24, January 20, 2017; October 8, September 27, August 13, 8 and 1, June 30 and 2, May 5 and 2, March 31 and 30, 2016, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide